Bioactive Carbohydrates and Dietary Fibre

Bioactive Carbohydrates and Dietary Fibre is a peer-reviewed journal from Elsevier, published in Amsterdam since 2013 and given to the chemistry, analysis and physiological action of fibre and other bioactive carbohydrates.《生物活性碳水化合物与膳食纤维》是一本 Elsevier 的同行评审期刊，2013 年起在阿姆斯特丹出版，专事膳食纤维及其他生物活性碳水化合物的化学、分析与生理作用。

The subject is narrow by design, sitting where carbohydrate chemistry meets nutrition, food technology and clinical measurement, and the papers it prints rarely stray from that junction.题材有意收窄，处在碳水化合物化学与营养学、食品工艺、临床测量的交汇处，所载论文很少远离这个接点。

What a fibre is made of, how it behaves in a food matrix and what it does once eaten are treated as one continuous question rather than three separate ones.纤维由什么构成、在食品基质中如何表现、被吃下之后起什么作用，被当作一个连续的问题，而非三个彼此分离的问题。

Clarivate assigned a 2025 Journal Impact Factor of 3.3, ranked the title 91st of 187 in food science and technology, and put its JCI at 0.7.Clarivate 给出的 2025 年影响因子为 3.3，该刊在食品科学与技术类目 187 种期刊中列第 91 位，JCI 为 0.7。

Scope

• The scope statement begins with a definition, naming dietary fibre and bioactive carbohydrates, polysaccharides, oligosaccharides and glycoproteins among them, as the materials the journal follows.范围说明先作界定，把膳食纤维与生物活性碳水化合物点名为刊物追踪的对象，多糖、寡糖与糖蛋白都在其中。

• Primary structure is the starting point, and work on monosaccharide composition, linkage pattern and the placement of side chains sits at the centre of the journal.一级结构是起点，单糖组成、连接方式与支链位置方面的研究处在刊物的中心。

• Molecular characteristics follow, with conformation, molecular weight, size and shape treated as the properties that decide how a fibre behaves in food and in the gut.分子特征随之而来，构象、分子量、尺寸与形状被视为决定纤维在食品与肠道中表现的属性。

• Analysis and physicochemical characterisation of soluble and insoluble fibre are named outright, which brings extraction, purification and instrumental measurement inside the remit.可溶与不可溶膳食纤维的分析及物理化学表征被明确点名，提取、纯化与仪器测定因此进入范围。

• Source material is drawn widely, from plants, fungi and animals to preparations made by biotechnology, and a paper is expected to say where its material came from.材料来源相当宽，植物、真菌、动物以及生物技术制备的产物都在其列，论文须交代材料的来处。

• Studies may be conducted in vitro, in cell culture, in animals or in human trials, and the design chosen is expected to carry the weight of the claim made.研究可在体外、细胞培养、动物或人体试验中开展，所选设计须撑得起所提主张。

• The declared aim is to explain how a bioactive carbohydrate acts, so a report of an effect that never touches mechanism sits at the edge of what the journal will take.刊物声明的目标是解释生物活性碳水化合物如何起作用，只报效应而不触及机制的稿件处在可接纳范围的边缘。

• Cholesterol lowering is one named bioactivity, covering total cholesterol and the LDL fraction, usually within a controlled dietary intervention.降胆固醇是被点名的活性之一，涵盖总胆固醇与 LDL 部分，通常置于受控膳食干预之内。

• Glucose and insulin responses are another, and post-prandial measurement is singled out because the glycaemic effect of a fibre depends on what it is eaten with.葡萄糖与胰岛素反应是另一项，餐后测量被单独提出，纤维的血糖效应取决于它与什么一同吃下。

• Fermentability in the gastrointestinal tract is a third, and the scope follows fibre through bacterial breakdown to short-chain fatty acids and shifts in community composition.胃肠道中的可发酵性是第三项，范围把纤维一路追到细菌降解、短链脂肪酸以及菌群组成的变化。

• Immune regulation, anti-inflammatory action, antioxidant capacity and activity against tumours are listed as further bioactivities open to submission.免疫调节、抗炎作用、抗氧化能力与抗肿瘤活性被列为同样欢迎投稿的其余活性。

• Interactions count as much as single components, so work on how fibre binds starch, protein, polyphenol or bile acid inside a food matrix stays within the scope.相互作用与单一组分同等重要，纤维在食品基质中如何结合淀粉、蛋白质、多酚或胆汁酸的研究仍在范围之内。

• Resistant starch and prebiotic oligosaccharides enter mainly through their physiological and technological behaviour, which is where the journal draws its boundary.抗性淀粉与益生元寡糖主要以生理与工艺行为的面貌进入，刊物的边界也划在这里。

• Two formats are accepted, the original study and the comprehensive review, and a review is expected to gather a literature into an argument instead of listing papers.接收两种体裁，原创研究与综合性综述，综述须把一支文献聚成论点，仅罗列论文不足以成篇。

• Neighbouring fields supply methods more than topics, so chromatography, rheology, spectroscopy and microbial sequencing appear as tools inside a carbohydrate question.相邻学科提供的是方法而非题目，色谱、流变、光谱与微生物测序以工具的身份出现在碳水化合物问题里。

History

• Volume one carries the year 2013, and the National Library of Medicine records Amsterdam as the place of publication from the first issue onward.第一卷的年份是 2013 年，美国国家医学图书馆的书目记录从创刊号起就把出版地记为阿姆斯特丹。

• Elsevier has held the title from that first year, and the journal has never passed between publishers, which keeps its imprint history unusually short.Elsevier 自第一年起就持有该刊，刊物未曾易主，出版沿革因此比多数老刊简短。

• A single number, 2212-6198, covers both the print and the electronic edition, sparing the journal the parallel registration that two numbers would require.单一号码 2212-6198 同时充当印刷版与电子版的标识，省去了纸电两号并行的登记工作。

• The title keeps the British spelling, and the JCR abbreviation BIOACT CARB DIET FIB follows the same word order as the name.刊名采用英式拼写，JCR 缩写 BIOACT CARB DIET FIB 与刊名保持同样的词序。

• Crossref registers two volume numbers for each recent year, 25 and 26 for 2021, 31 and 32 for 2024, 33 and 34 for 2025, and 35 and 36 for 2026.Crossref 为近年每年登记两个卷号，2021 年为第 25 与第 26 卷，2024 年为第 31 与第 32 卷，2025 年为第 33 与第 34 卷，2026 年为第 35 与第 36 卷。

• The early volumes each carried two numbered issues, four to a year, which is the quarterly frequency the catalogue records. From volume 9 the issue field falls empty in the Crossref record.早年每卷各出两期，一年四期，目录记下的季刊刊期即由此而来；自第 9 卷起，Crossref 记录中的期号一栏开始空置。

• Indexing came through Clarivate's Emerging Sources Citation Index rather than the core science edition, and the 2025 category listing still carries the ESCI tag.收录走的是 Clarivate 的 Emerging Sources Citation Index，而非核心的科学版，2025 年的类目清单仍标注 ESCI。

• NLM's record carries no list of indexing sources, and neither MEDLINE nor PubMed covers the journal, so its papers are reached through the publisher's platform.NLM 的书目记录没有收录源清单，MEDLINE 与 PubMed 均未覆盖该刊，论文主要通过出版方的平台获取。

• The impact factor stood at 3.6 in 2024 and eased to 3.3 in 2025, a shift small enough to fall inside ordinary year-to-year variation.影响因子 2024 年为 3.6，2025 年回落到 3.3，这一幅度仍在年际波动的常态之内。

• In the 2025 assessment the title held a JCI of 0.7 and a percentile of 51.6, a little above the middle of its food science category.2025 年评估中该刊 JCI 为 0.7，百分位为 51.6，略高于食品科学类目的中线。

• Output is compact, at 47 articles in the 2025 volume, while a citation total of 1467 and a cited half-life of 5.2 years describe a small and durable literature.载文量不大，2025 年卷为 47 篇，总被引 1467 次与被引半衰期 5.2 年勾勒出一支规模有限却耐读的文献。

• Reading is mostly by subscription, and Clarivate puts the gold open-access share at 8.13 per cent, so openly licensed papers remain the exception.阅读大体依靠订阅，Clarivate 记录的金色开放获取比例为 8.13%，开放许可的论文仍属少数。

Editors

• The journal describes itself as peer reviewed, and every accepted paper has passed external assessment before an editorial decision is recorded.刊物自述为同行评审期刊，每篇录用论文在编辑决定形成之前都经过外部评估。

• Original studies and comprehensive reviews form two streams, and both enter the same assessment path once a manuscript arrives.原创研究与综合性综述构成两条来稿通道，稿件到手后走同一条评估路径。

• Submission runs through the publisher's online platform, and the cover letter is where authors set out what the work adds to carbohydrate science.投稿经出版方的在线平台完成，投稿信是作者陈述研究为碳水化合物科学增添了什么的地方。

• An initial editorial check asks whether the paper concerns fibre or a bioactive carbohydrate at all, and work on unrelated compounds is sent elsewhere.编辑初审先判断论文是否真的涉及膳食纤维或生物活性碳水化合物，与两者无关的化合物研究会被转投。

• Reviewer choice has to span two competences at once, polymer and analytical chemistry on one side, nutrition and trial design on the other.送审人选的搭配要同时覆盖两种能力，一边是多糖与分析化学，一边是营养学与试验设计。

• Human intervention work is read for dose, duration and the population studied, since a glycaemic or lipid claim rests on all three.人体干预研究按剂量、周期与研究人群来读，血糖或血脂方面的主张依赖这三项。

• Ethical approval and registration details are expected with any study that enrols participants, in line with the publisher's standing policy.凡招募受试者的研究，都须随稿提交伦理批准与注册信息，这与出版方的一贯政策一致。

• Fermentation and animal work is judged on how far the substrate is characterised, because an uncharacterised fibre cannot be compared with anything.发酵与动物实验按底物的表征程度来评判，未经表征的纤维无法与任何结果相比。

• Papers that quantify fibre or map a polysaccharide structure are pressed on method validation, including how recovery and detection limits were established.涉及纤维定量或多糖结构解析的论文会被追问方法验证，回收率与检出限如何确定也在追问之列。

• Production stays with the publisher, which handles typesetting, DOI registration and metadata deposit, so authors deal with one organisation throughout.生产环节留在出版方手中，排版、DOI 注册与元数据登记由其完成，作者全程只与一个机构打交道。

• Most papers appear behind the subscription wall, and a gold share of 8.13 per cent shows that the open route is taken by a minority of authors.多数论文在订阅墙之后发表，金色占比只有 8.13%，走开放获取路线的作者因此是少数。